Scilex Holding Co Files 8-K on Financials

TL;DR

Scilex Holding Co dropped an 8-K on July 1st detailing financials and stock info.

AI Summary

On July 1, 2024, Scilex Holding Company filed an 8-K report detailing its financial condition and results of operations. The filing includes information about its common stock and warrants to purchase common stock, with a par value of $0.00001 per share.

Why It Matters

This filing provides investors with an update on Scilex Holding Company's financial status and operational results, which can influence investment decisions.

Risk Assessment

Risk Level: low — This is a routine 8-K filing providing standard financial and operational information.

Key Numbers

• 001-39852 — Commission File Number (Identifies the specific SEC filing for Scilex Holding Co.)
• $0.00001 — Par Value per Share (Represents the nominal value assigned to each share of Scilex Holding Co.'s common stock.)

Key Players & Entities

• Scilex Holding Co (company) — Registrant
• July 1, 2024 (date) — Date of Report
• Delaware (jurisdiction) — State of incorporation
• 001-39852 (filing_id) — Commission File Number
• $0.00001 (dollar_amount) — Par value per share of common stock

FAQ

Key Financial Figures

• $0.0001 — ch registered Common stock, par value $0.0001 per share SCLX The Nasdaq Stock Mar
• $11.50 — mon stock, each at an exercise price of $11.50 per share SCLXW The Nasdaq Stock Ma
• $7.5 million — nded June 30, 2024 were in the range of $7.5 million to $9.0 million, compared to $4.4 milli
• $9.0 m — 24 were in the range of $7.5 million to $9.0 million, compared to $4.4 million for the
• $4.4 million — .5 million to $9.0 million, compared to $4.4 million for the same period last year, represen
• $15.8 million — nded June 30, 2024 were in the range of $15.8 million to $17.5 million, compared to $12.3 mil
• $17.5 m — 4 were in the range of $15.8 million to $17.5 million, compared to $12.3 million for th
• $12.3 million — 8 million to $17.5 million, compared to $12.3 million for the same period last year, represen
• $7.8 million — nded June 30, 2024 were in the range of $7.8 million to $9.5 million, compared to $4.4 milli
• $9.5 m — 24 were in the range of $7.8 million to $9.5 million, compared to $4.4 million for the
• $16.4 million — nded June 30, 2024 were in the range of $16.4 million to $18.2 million, compared to $12.6 mil
• $18.2 m — 4 were in the range of $16.4 million to $18.2 million, compared to $12.6 million for th
• $12.6 million — 4 million to $18.2 million, compared to $12.6 million for the same period last year, represen
• $7.0 million — s of June 30, 2024 were in the range of $7.0 million to $10.0 million, compared to $34.1 mil
• $10.0 m — 24 were in the range of $7.0 million to $10.0 million, compared to $34.1 million as of

Filing Documents

• sclx-20240701.htm (8-K) — 45KB
• sclx-ex99_1.htm (EX-99.1) — 33KB
• img191798281_0.jpg (GRAPHIC) — 14KB
• img191798281_1.jpg (GRAPHIC) — 8KB
• img191798281_2.jpg (GRAPHIC) — 11KB
• img191798281_3.jpg (GRAPHIC) — 17KB
• 0000950170-24-079287.txt ( ) — 309KB
• sclx-20240701.xsd (EX-101.SCH) — 54KB
• sclx-20240701_htm.xml (XML) — 6KB

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. Scilex Holding Company (the "Company") is providing certain preliminary unaudited financial results for the month ended June 30, 2024 and quarter ended June 30, 2024 based on currently available information. The Company's independent auditor has not reviewed or audited these preliminary estimated financial results. The Company's actual results may differ materially from these preliminary financial results, and may be outside the estimated ranges. This preliminary financial data has been prepared by and is the responsibility of the Company. The Company has not fully completed its review of these preliminary financial results for the month ended June 30, 2024 and quarter ended June 30, 2024. The Company estimates that: ZTlido net sales for the month ended June 30, 2024 were in the range of $7.5 million to $9.0 million, compared to $4.4 million for the same period last year, representing growth in the range of approximately 70% to 104%. ZTlido net sales for the quarter ended June 30, 2024 were in the range of $15.8 million to $17.5 million, compared to $12.3 million for the same period last year, representing growth in the range of approximately 28% to 42%. Total product net sales for the month ended June 30, 2024 were in the range of $7.8 million to $9.5 million, compared to $4.4 million for the same period last year, representing growth in the range of approximately 77% to 116%. Total product net sales for the quarter ended June 30, 2024 were in the range of $16.4 million to $18.2 million, compared to $12.6 million for the same period last year, representing growth in the range of approximately 30% to 44%. Cash and cash equivalents as of June 30, 2024 were in the range of $7.0 million to $10.0 million, compared to $34.1 million as of June 30, 2023. Accounts receivable as of June 30, 2024 were in the range of $38.0 million to $40.0 million, compared to $27.6 million as of June 30, 2023. Operat

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. 2 Exhibit Number Description 99.1 Press Release, dated July 1, 2024. 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL). 3

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCILEX HOLDING COMPANY By: /s/ Jaisim Shah Name: Jaisim Shah Date: July 1, 2024 Title: Chief Executive Officer and President 4

View Full Filing

View this 8-K filing on SEC EDGAR